The 2019 CCS Position Statement for Transcatheter Aortic Valve Implantation incorporates clinical evidence to provide a practical framework for patient selection that relies on individual patient evaluation of risk and benefit from either TAVI or surgical aortic valve replacement.
In the last decade, transcatheter aortic valve implantation (TAVI) – an innovative, non-invasive surgical procedure – has become the preferred treatment option for many heart patients. Yet the latest pan-Canadian data on TAVI care shows that access is highly variable across Canada and that healthcare resources are not keeping pace with the growing healthcare need.
The Canadian Cardiovascular Society (CCS) is pleased to recognize seven outstanding Canadian researchers whose five projects have been selected to receive funding as part of the Early Career Atrial and Arrythmia (ECA3) Research Award.
The Canadian Cardiovascular Society (CCS) has announced the three finalists in the CCS-Bayer Vascular Awards competition.
Despite best efforts and major support at the highest level of government, federal Budget 2019 shows no sign of funds for the CCS Quality Project. Without this year’s federal funding commitment, the CCS will have no choice but to scale down the project, limiting our ability to advance quality cardiovascular care in Canada.